Safety of SARS-CoV2 vaccination and COVID-19 short-term outcome in pediatric acquired demyelinating disorders of central nervous system: A single center experience
暂无分享,去创建一个
Massimiliano Valeriani | P. Palma | F. Vigevano | R. Moavero | L. Papetti | M. Ferilli | F. Ursitti | G. Sforza | S. Tarantino | G. Monte | Martina Proietti Checchi | Elena Panella
[1] C. Pozzilli,et al. Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in , 2022, Frontiers in Immunology.
[2] P. Manganotti,et al. Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD , 2021, Multiple Sclerosis and Related Disorders.
[3] I. Ismail,et al. A systematic review of cases of CNS demyelination following COVID-19 vaccination , 2021, Journal of Neuroimmunology.
[4] J. Drulovic,et al. COVID-19 and vaccination against SARS-CoV-2 in patients with neuromyelitis optica spectrum disorders , 2021, Multiple Sclerosis and Related Disorders.
[5] H. Kearney,et al. Vaccine hesitancy among people with multiple sclerosis , 2021, Multiple Sclerosis and Related Disorders.
[6] G. Cutter,et al. COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America , 2021, Neurology: Neuroimmunology & Neuroinflammation.
[7] I. Lotan,et al. Patient-reported safety and tolerability of the COVID-19 vaccines in persons with rare neuroimmunological diseases , 2021, Multiple Sclerosis and Related Disorders.
[8] H. Lopez-Gatell,et al. Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study , 2021, Clinical Immunology.
[9] A. Achiron,et al. COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021 , 2021, Multiple Sclerosis Journal.
[10] A. Carrá,et al. COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America: COVID-19 in MS and NMOSD patients in LATAM. , 2021, Multiple sclerosis and related disorders.
[11] K. Schmierer,et al. Protecting people with multiple sclerosis through vaccination , 2020, Practical Neurology.
[12] Chi-Jung Wu,et al. Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines , 2020, Biomedical Journal.
[13] Ping Li,et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020 .